ライフサイエンスコーパス: swollen joint

1 base guidelines on the management of the hot-swollen joint.

2 (RA) is characterised by painful, stiff and swollen joints.

3 igoarthritis was defined as <5 tender and/or swollen joints.

4 , defined as DAS28-CRP of 3.2 or less and no swollen joints.

5 ednisone because it helps control tender and swollen joints.

6 r levels of radiologic damage, and had fewer swollen joints.

7 d had at least four tender and at least four swollen joints.

8 S score of 0.6 units or more, and at least 2 swollen joints.

9 d a mean age of (44 +/- 10 years), number of swollen joints (3 +/- 3), number of tender joints (5 +/-

10 ntly more tender joints (17 versus 11), more swollen joints (8 versus 7), more frequent rheumatoid fa

11 interval, .14-.79) but more likely to have a swollen joint (adjusted odds ratio, 3.68; 95% confidence

12 ges 18-70 years and had active PsA (> or = 3 swollen joints and > or = 3 tender joints) despite treat

13 20 (ACR20) response (>=20% fewer tender and swollen joints and >=20% improvement in three of five ot

14 nt from baseline in the number of tender and swollen joints and at least three of five other importan

15 nt from baseline in the number of tender and swollen joints and at least three other important domain

16 % reduction in the number of both tender and swollen joints and improvement in at least three of five

17 , respectively, in the numbers of tender and swollen joints and in at least three of five important d

18 autoimmune disease characterized by painful swollen joints and significant disabilities.

19 of active joints (defined as the sum of the swollen joints and the tender joints) at week 24.

20 ber of tender joints, 1.05 for the number of swollen joints, and 1.20 for the ESR).

21 rly diabetes mellitus or hypertension), many swollen joints, and a high cumulative dose of glucocorti

22 bjects by measuring the number of tender and swollen joints, anti-citrullinated protein antibody and

23 +)Th17 cells also correlated with numbers of swollen joints as late as one year post-therapy.

24 gest that the first abnormality to appear in swollen joints associated with spondyloarthropathy is an

25 entage reduction in the number of tender and swollen joints at 6 months was 56% and 47% in the 25-mg

26 vels, the presence of nodules, and number of swollen joints at baseline were all predictive of radiog

27 percent reduction in the number of tender or swollen joints at three months was 61 percent, as compar

28 th active psoriatic arthritis (at least five swollen joints, at least five tender joints, and C-react

29 RA had no change in the number of painful or swollen joints but had significant reductions in self-re

30 ve psoriatic arthritis (>/=5 tender and >/=5 swollen joints, C-reactive protein >/=3.0 mg/L) were ran

31 ined remission (defined as DAS28 <2.6 with a swollen joint count </=four, persisting for at least 24

32 ne (P = 0.005) and changes at 2 years in the swollen joint count (P = 0.002), total skin score (P = 0

33 DAS28, visual analog scales (VAS), age, and swollen joint count (SJC) as important characteristics f

34 nder joint count (TJC) using 68 joints and a swollen joint count (SJC) using 66 joints (66/68-joint c

35 (mean tender/painful joint count 29.4, mean swollen joint count 17.4, mean erythrocyte sedimentation

36 disease-modifying antirheumatic drugs; mean swollen joint count 8.6-10.4).

37 Swollen joint count also fell (-2.69 vs -0.53; mean diff

38 pects of PSPP were related to depression and swollen joint count but not functional fitness.

39 ), while a combination of MMP-3, CTX-II, and swollen joint count formed the best longitudinal AUC mod

40 nt count of 44 joints [TJC44]) and swelling (swollen joint count of 44 joints [SJC44]) at 26 wk using

41 ve protein level and an increase in the mean swollen joint count were noted during the study period.

42 The Ritchie Articular Index, swollen joint count, and Disease Activity Score were sig

43 ician's assessments of disease activity, the swollen joint count, and function (by Health Assessment

44 onnaire Disability Index, total Sharp score, swollen joint count, and presence of osteophytes (osteoa

45 : (a) when scores on the tender joint count, swollen joint count, CRP (in mg/dl), and patient global

46 The swollen joint count, physical function, and patient-asse

47 A 70-90% reduction in the swollen joint count, tender joint count, and C-reactive

48 moking status, HAQ score, RF positivity, and swollen joint counts (HR 3.3 [95% CI 1.4-7.6]).

49 Higher swollen joint counts and higher average C-reactive prote

50 ynovial fluid correlated with the tender and swollen joint counts and the activity scores on the 28-j

51 f 20% improvement (ACR20) and the tender and swollen joint counts at the end of treatment were the pr

52 tivity Score, and > or =50% decreases in the swollen joint counts during the first 2 years of followu

53 less than 5% improvement in both tender and swollen joint counts entered masked early-escape and wer

54 Mean reductions in tender and swollen joint counts in patients receiving alefacept plu

55 nalyzable" cases (paired data for tender and swollen joint counts plus > or =3 of the 5 secondary cri

56 ere patients with paired data for tender and swollen joint counts plus at least 3 of the following cr

57 naire score, rheumatoid factor, nodules, and swollen joint counts were not.

58 easure scored as 1 or less (e.g., tender and swollen joint counts, C-reactive protein [CRP] level, an

59 Tender and swollen joint counts, pain and stiffness scores were all

60 Outcome measures including tender and swollen joint counts, pain assessment on a 10-point visu

61 ues for rheumatoid factor and the tender and swollen joint counts.

62 Eighty-four subjects (14.0%) had > or =1 swollen joint, designated as IA on joint examination.

63 s in the components of DAS28-ESR (tender and swollen joints, ESR, and visual analog scale for general

64 Adults with two or more swollen joints for at least 4 weeks were recruited from

65 were associated only with one QoL domain and swollen joints for none, while pain and stiffness were a

66 comes assessed were the number of tender and swollen joints, grip strength, and the erythrocyte sedim

67 ts and 13 patients, respectively, and missed swollen joints in 11 patients and 2 patients, respective

68 pared with those in 2000: median 12 versus 5 swollen joints, Larsen radiographic score 20 versus 3, e

69 der joints (n = 29) and 27% of patients with swollen joints (n = 23).

70 ); and 4) assessor-only (median of number of swollen joints, number of tender joints, and global stat

71 ted: 1) ACR-N (lowest of 3 values: number of swollen joints, number of tender joints, and median of t

72 sex, current smokers had significantly fewer swollen joints (OR 0.61, 95% CI 0.37-0.98).

73 associated with a lower number of tender and swollen joints (P < 0.05) and a lower score for the phys

74 nt-reported warm joint, any patient-reported swollen joint, patient-reported pain at rest score of >3

75 were the number of tender joints, number of swollen joints, physician and patient global assessments

76 ents who present with an acutely painful and swollen joint, prompt identification and treatment of se

77 IA was defined as > or =1 swollen joint suggestive of synovitis on joint examinati

78 The number of swollen joints, tender joints, ESR and DAS-28 were more

79 who is feverish and toxic, with a single hot swollen joint that has limited movement and is often rig

80 autoimmune disease characterized by painful, swollen joints that can severely impair physical functio

81 weekly dosing when assessed by the number of swollen joints, the investigator and patient assessments

82 The numbers of tender and swollen joints, the Visual Analog Scale (VAS) scores for

83 RDs was increased according to protocol, and swollen joints were injected with triamcinolone acetonid

84 flare, joint pain at rest, warm joints, and swollen joints were most strongly associated with presen

85 s-C-reactive protein [DAS28-CRP] <3.2 and no swollen joints) were enrolled between April 2012 and Jun

86 Twenty-three patients with active RA (>5 swollen joints) were enrolled into a randomized, double-

87 unt (at least 10 tender/painful joints and 7 swollen joints) were stratified according to DMARD intol

88 e of 68 tender joints and four or more of 66 swollen joints, who were refractory or intolerant to pre